Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
25.13
-0.17 (-0.67%)
At close: Sep 2, 2026, 4:00 PM EDT
25.28
+0.15 (0.60%)
Pre-market: Sep 3, 2026, 4:28 AM EDT
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $1.5 billion as of September 2, 2026. Its market cap has increased by 122.08% in one year.
Market Cap
1.50B
Enterprise Value
1.15B
1-Year Change
122.08%
Ranking
Category
Stock Price
$25.13
ChartMarket Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $1.50B, an increase of 129.08%. That is a compound annual growth rate of 18.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 1.50B | 6.88% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novavax | 1.55B |
| Avalyn Pharma | 1.54B |
| Bicara Therapeutics | 1.53B |
| LB Pharmaceuticals | 1.52B |
| Innoviva | 1.50B |
| First Tracks Biotherapeutics | 1.49B |
| ArriVent BioPharma | 1.48B |
| Maze Therapeutics | 1.48B |